nodes	percent_of_prediction	percent_of_DWPC	metapath
Halofantrine—CYP3A4—Thiotepa—sarcoma	0.172	0.218	CbGbCtD
Halofantrine—CYP3A5—Vincristine—sarcoma	0.13	0.165	CbGbCtD
Halofantrine—CYP3A5—Etoposide—sarcoma	0.12	0.151	CbGbCtD
Halofantrine—CYP2C8—Etoposide—sarcoma	0.115	0.145	CbGbCtD
Halofantrine—CYP3A4—Mitoxantrone—sarcoma	0.0739	0.0936	CbGbCtD
Halofantrine—CYP3A4—Vincristine—sarcoma	0.0509	0.0644	CbGbCtD
Halofantrine—CYP2D6—Doxorubicin—sarcoma	0.05	0.0633	CbGbCtD
Halofantrine—CYP3A4—Etoposide—sarcoma	0.0466	0.059	CbGbCtD
Halofantrine—CYP3A4—Doxorubicin—sarcoma	0.0318	0.0402	CbGbCtD
Halofantrine—Altered state of consciousness—Vincristine—sarcoma	0.00712	0.0339	CcSEcCtD
Halofantrine—Platelet count decreased—Mitoxantrone—sarcoma	0.00538	0.0256	CcSEcCtD
Halofantrine—Pulmonary oedema—Thiotepa—sarcoma	0.0033	0.0157	CcSEcCtD
Halofantrine—Rigors—Etoposide—sarcoma	0.00326	0.0155	CcSEcCtD
Halofantrine—Stomatitis—Thiotepa—sarcoma	0.00202	0.00962	CcSEcCtD
Halofantrine—Stomatitis—Dactinomycin—sarcoma	0.00201	0.00955	CcSEcCtD
Halofantrine—Rigors—Epirubicin—sarcoma	0.00183	0.0087	CcSEcCtD
Halofantrine—Stomatitis—Vincristine—sarcoma	0.00179	0.00853	CcSEcCtD
Halofantrine—Stomatitis—Mitoxantrone—sarcoma	0.00175	0.00831	CcSEcCtD
Halofantrine—Tinnitus—Thiotepa—sarcoma	0.00174	0.00826	CcSEcCtD
Halofantrine—Rigors—Doxorubicin—sarcoma	0.00169	0.00805	CcSEcCtD
Halofantrine—Chills—Thiotepa—sarcoma	0.00167	0.00795	CcSEcCtD
Halofantrine—Arrhythmia—Thiotepa—sarcoma	0.00166	0.00792	CcSEcCtD
Halofantrine—Chills—Dactinomycin—sarcoma	0.00166	0.00789	CcSEcCtD
Halofantrine—Back pain—Thiotepa—sarcoma	0.00157	0.00746	CcSEcCtD
Halofantrine—Ill-defined disorder—Dactinomycin—sarcoma	0.00149	0.0071	CcSEcCtD
Halofantrine—Stomatitis—Etoposide—sarcoma	0.00145	0.00691	CcSEcCtD
Halofantrine—Malaise—Dactinomycin—sarcoma	0.00145	0.00691	CcSEcCtD
Halofantrine—Chills—Mitoxantrone—sarcoma	0.00144	0.00687	CcSEcCtD
Halofantrine—Arrhythmia—Mitoxantrone—sarcoma	0.00144	0.00684	CcSEcCtD
Halofantrine—Cough—Thiotepa—sarcoma	0.00141	0.00673	CcSEcCtD
Halofantrine—Convulsion—Thiotepa—sarcoma	0.0014	0.00668	CcSEcCtD
Halofantrine—Back pain—Vincristine—sarcoma	0.00139	0.00662	CcSEcCtD
Halofantrine—Arthralgia—Thiotepa—sarcoma	0.00138	0.00657	CcSEcCtD
Halofantrine—Myalgia—Thiotepa—sarcoma	0.00138	0.00657	CcSEcCtD
Halofantrine—Myalgia—Dactinomycin—sarcoma	0.00137	0.00652	CcSEcCtD
Halofantrine—Back pain—Mitoxantrone—sarcoma	0.00135	0.00644	CcSEcCtD
Halofantrine—Discomfort—Dactinomycin—sarcoma	0.00135	0.00644	CcSEcCtD
Halofantrine—Confusional state—Thiotepa—sarcoma	0.00133	0.00635	CcSEcCtD
Halofantrine—Pulmonary oedema—Epirubicin—sarcoma	0.00133	0.00633	CcSEcCtD
Halofantrine—Abnormal vision—Epirubicin—sarcoma	0.0013	0.0062	CcSEcCtD
Halofantrine—Ill-defined disorder—Mitoxantrone—sarcoma	0.0013	0.00618	CcSEcCtD
Halofantrine—Malaise—Mitoxantrone—sarcoma	0.00126	0.00601	CcSEcCtD
Halofantrine—Anorexia—Thiotepa—sarcoma	0.00126	0.006	CcSEcCtD
Halofantrine—Anorexia—Dactinomycin—sarcoma	0.00125	0.00596	CcSEcCtD
Halofantrine—Convulsion—Vincristine—sarcoma	0.00124	0.00593	CcSEcCtD
Halofantrine—Pulmonary oedema—Doxorubicin—sarcoma	0.00123	0.00585	CcSEcCtD
Halofantrine—Myalgia—Vincristine—sarcoma	0.00122	0.00582	CcSEcCtD
Halofantrine—Cough—Mitoxantrone—sarcoma	0.00122	0.00581	CcSEcCtD
Halofantrine—Convulsion—Mitoxantrone—sarcoma	0.00121	0.00577	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Thiotepa—sarcoma	0.0012	0.00574	CcSEcCtD
Halofantrine—Abnormal vision—Doxorubicin—sarcoma	0.0012	0.00573	CcSEcCtD
Halofantrine—Chills—Etoposide—sarcoma	0.0012	0.00571	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.0012	0.00569	CcSEcCtD
Halofantrine—Myalgia—Mitoxantrone—sarcoma	0.00119	0.00567	CcSEcCtD
Halofantrine—Arthralgia—Mitoxantrone—sarcoma	0.00119	0.00567	CcSEcCtD
Halofantrine—Chest pain—Mitoxantrone—sarcoma	0.00119	0.00567	CcSEcCtD
Halofantrine—Paraesthesia—Thiotepa—sarcoma	0.00119	0.00565	CcSEcCtD
Halofantrine—Discomfort—Mitoxantrone—sarcoma	0.00118	0.0056	CcSEcCtD
Halofantrine—Anaphylactic shock—Vincristine—sarcoma	0.00117	0.00558	CcSEcCtD
Halofantrine—Dyspepsia—Thiotepa—sarcoma	0.00116	0.00554	CcSEcCtD
Halofantrine—Confusional state—Mitoxantrone—sarcoma	0.00115	0.00548	CcSEcCtD
Halofantrine—Decreased appetite—Thiotepa—sarcoma	0.00115	0.00547	CcSEcCtD
Halofantrine—Anaphylactic shock—Mitoxantrone—sarcoma	0.00114	0.00544	CcSEcCtD
Halofantrine—Decreased appetite—Dactinomycin—sarcoma	0.00114	0.00543	CcSEcCtD
Halofantrine—Fatigue—Thiotepa—sarcoma	0.00114	0.00543	CcSEcCtD
Halofantrine—Fatigue—Dactinomycin—sarcoma	0.00113	0.00539	CcSEcCtD
Halofantrine—Constipation—Thiotepa—sarcoma	0.00113	0.00538	CcSEcCtD
Halofantrine—Back pain—Etoposide—sarcoma	0.00113	0.00536	CcSEcCtD
Halofantrine—Anorexia—Vincristine—sarcoma	0.00112	0.00532	CcSEcCtD
Halofantrine—Cerebrovascular accident—Epirubicin—sarcoma	0.00111	0.00526	CcSEcCtD
Halofantrine—Feeling abnormal—Thiotepa—sarcoma	0.00109	0.00519	CcSEcCtD
Halofantrine—Anorexia—Mitoxantrone—sarcoma	0.00109	0.00518	CcSEcCtD
Halofantrine—Feeling abnormal—Dactinomycin—sarcoma	0.00108	0.00515	CcSEcCtD
Halofantrine—Gastrointestinal pain—Thiotepa—sarcoma	0.00108	0.00515	CcSEcCtD
Halofantrine—Ill-defined disorder—Etoposide—sarcoma	0.00108	0.00514	CcSEcCtD
Halofantrine—Gastrointestinal pain—Dactinomycin—sarcoma	0.00107	0.00511	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Vincristine—sarcoma	0.00107	0.00509	CcSEcCtD
Halofantrine—Paraesthesia—Vincristine—sarcoma	0.00105	0.00501	CcSEcCtD
Halofantrine—Urticaria—Thiotepa—sarcoma	0.00105	0.005	CcSEcCtD
Halofantrine—Malaise—Etoposide—sarcoma	0.00105	0.005	CcSEcCtD
Halofantrine—Face oedema—Epirubicin—sarcoma	0.00105	0.00498	CcSEcCtD
Halofantrine—Abdominal pain—Thiotepa—sarcoma	0.00105	0.00498	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00104	0.00495	CcSEcCtD
Halofantrine—Abdominal pain—Dactinomycin—sarcoma	0.00104	0.00494	CcSEcCtD
Halofantrine—Paraesthesia—Mitoxantrone—sarcoma	0.00103	0.00488	CcSEcCtD
Halofantrine—Cerebrovascular accident—Doxorubicin—sarcoma	0.00102	0.00487	CcSEcCtD
Halofantrine—Decreased appetite—Vincristine—sarcoma	0.00102	0.00485	CcSEcCtD
Halofantrine—Cough—Etoposide—sarcoma	0.00102	0.00484	CcSEcCtD
Halofantrine—Fatigue—Vincristine—sarcoma	0.00101	0.00481	CcSEcCtD
Halofantrine—Convulsion—Etoposide—sarcoma	0.00101	0.0048	CcSEcCtD
Halofantrine—Dyspepsia—Mitoxantrone—sarcoma	0.00101	0.00479	CcSEcCtD
Halofantrine—Constipation—Vincristine—sarcoma	0.001	0.00477	CcSEcCtD
Halofantrine—Decreased appetite—Mitoxantrone—sarcoma	0.000993	0.00473	CcSEcCtD
Halofantrine—Chest pain—Etoposide—sarcoma	0.000991	0.00472	CcSEcCtD
Halofantrine—Orthostatic hypotension—Epirubicin—sarcoma	0.00099	0.00471	CcSEcCtD
Halofantrine—Fatigue—Mitoxantrone—sarcoma	0.000985	0.00469	CcSEcCtD
Halofantrine—Discomfort—Etoposide—sarcoma	0.000979	0.00466	CcSEcCtD
Halofantrine—Constipation—Mitoxantrone—sarcoma	0.000977	0.00465	CcSEcCtD
Halofantrine—Face oedema—Doxorubicin—sarcoma	0.000968	0.00461	CcSEcCtD
Halofantrine—Gastrointestinal pain—Vincristine—sarcoma	0.000959	0.00457	CcSEcCtD
Halofantrine—Confusional state—Etoposide—sarcoma	0.000958	0.00456	CcSEcCtD
Halofantrine—Anaphylactic shock—Etoposide—sarcoma	0.00095	0.00452	CcSEcCtD
Halofantrine—Asthenia—Thiotepa—sarcoma	0.000949	0.00452	CcSEcCtD
Halofantrine—Abdominal distension—Epirubicin—sarcoma	0.000943	0.00449	CcSEcCtD
Halofantrine—Asthenia—Dactinomycin—sarcoma	0.000942	0.00448	CcSEcCtD
Halofantrine—Feeling abnormal—Mitoxantrone—sarcoma	0.000941	0.00448	CcSEcCtD
Halofantrine—Pruritus—Thiotepa—sarcoma	0.000936	0.00445	CcSEcCtD
Halofantrine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000934	0.00445	CcSEcCtD
Halofantrine—Abdominal pain—Vincristine—sarcoma	0.000927	0.00441	CcSEcCtD
Halofantrine—Orthostatic hypotension—Doxorubicin—sarcoma	0.000916	0.00436	CcSEcCtD
Halofantrine—Urticaria—Mitoxantrone—sarcoma	0.000907	0.00432	CcSEcCtD
Halofantrine—Anorexia—Etoposide—sarcoma	0.000906	0.00431	CcSEcCtD
Halofantrine—Diarrhoea—Thiotepa—sarcoma	0.000905	0.00431	CcSEcCtD
Halofantrine—Abdominal pain—Mitoxantrone—sarcoma	0.000903	0.0043	CcSEcCtD
Halofantrine—Diarrhoea—Dactinomycin—sarcoma	0.000898	0.00428	CcSEcCtD
Halofantrine—Dizziness—Thiotepa—sarcoma	0.000875	0.00416	CcSEcCtD
Halofantrine—Abdominal distension—Doxorubicin—sarcoma	0.000872	0.00415	CcSEcCtD
Halofantrine—Pollakiuria—Epirubicin—sarcoma	0.000865	0.00412	CcSEcCtD
Halofantrine—Paraesthesia—Etoposide—sarcoma	0.000853	0.00406	CcSEcCtD
Halofantrine—Asthenia—Vincristine—sarcoma	0.000841	0.00401	CcSEcCtD
Halofantrine—Vomiting—Thiotepa—sarcoma	0.000841	0.004	CcSEcCtD
Halofantrine—Vomiting—Dactinomycin—sarcoma	0.000835	0.00397	CcSEcCtD
Halofantrine—Rash—Thiotepa—sarcoma	0.000834	0.00397	CcSEcCtD
Halofantrine—Dermatitis—Thiotepa—sarcoma	0.000833	0.00397	CcSEcCtD
Halofantrine—Headache—Thiotepa—sarcoma	0.000828	0.00394	CcSEcCtD
Halofantrine—Rash—Dactinomycin—sarcoma	0.000828	0.00394	CcSEcCtD
Halofantrine—Decreased appetite—Etoposide—sarcoma	0.000826	0.00393	CcSEcCtD
Halofantrine—Asthenia—Mitoxantrone—sarcoma	0.000819	0.0039	CcSEcCtD
Halofantrine—Fatigue—Etoposide—sarcoma	0.000819	0.0039	CcSEcCtD
Halofantrine—Stomatitis—Epirubicin—sarcoma	0.000814	0.00387	CcSEcCtD
Halofantrine—Constipation—Etoposide—sarcoma	0.000812	0.00387	CcSEcCtD
Halofantrine—Diarrhoea—Vincristine—sarcoma	0.000802	0.00382	CcSEcCtD
Halofantrine—Pollakiuria—Doxorubicin—sarcoma	0.0008	0.00381	CcSEcCtD
Halofantrine—Nausea—Thiotepa—sarcoma	0.000786	0.00374	CcSEcCtD
Halofantrine—Feeling abnormal—Etoposide—sarcoma	0.000783	0.00373	CcSEcCtD
Halofantrine—Diarrhoea—Mitoxantrone—sarcoma	0.000781	0.00372	CcSEcCtD
Halofantrine—Nausea—Dactinomycin—sarcoma	0.00078	0.00371	CcSEcCtD
Halofantrine—Gastrointestinal pain—Etoposide—sarcoma	0.000777	0.0037	CcSEcCtD
Halofantrine—Dizziness—Vincristine—sarcoma	0.000775	0.00369	CcSEcCtD
Halofantrine—Urticaria—Etoposide—sarcoma	0.000755	0.00359	CcSEcCtD
Halofantrine—Stomatitis—Doxorubicin—sarcoma	0.000753	0.00359	CcSEcCtD
Halofantrine—Abdominal pain—Etoposide—sarcoma	0.000751	0.00358	CcSEcCtD
Halofantrine—Vomiting—Vincristine—sarcoma	0.000746	0.00355	CcSEcCtD
Halofantrine—Rash—Vincristine—sarcoma	0.000739	0.00352	CcSEcCtD
Halofantrine—Dermatitis—Vincristine—sarcoma	0.000739	0.00352	CcSEcCtD
Halofantrine—Headache—Vincristine—sarcoma	0.000735	0.0035	CcSEcCtD
Halofantrine—Vomiting—Mitoxantrone—sarcoma	0.000726	0.00346	CcSEcCtD
Halofantrine—Visual impairment—Epirubicin—sarcoma	0.000722	0.00344	CcSEcCtD
Halofantrine—Rash—Mitoxantrone—sarcoma	0.00072	0.00343	CcSEcCtD
Halofantrine—Dermatitis—Mitoxantrone—sarcoma	0.000719	0.00343	CcSEcCtD
Halofantrine—Headache—Mitoxantrone—sarcoma	0.000715	0.00341	CcSEcCtD
Halofantrine—Tinnitus—Epirubicin—sarcoma	0.000699	0.00333	CcSEcCtD
Halofantrine—Nausea—Vincristine—sarcoma	0.000697	0.00332	CcSEcCtD
Halofantrine—Asthenia—Etoposide—sarcoma	0.000682	0.00325	CcSEcCtD
Halofantrine—Nausea—Mitoxantrone—sarcoma	0.000678	0.00323	CcSEcCtD
Halofantrine—Chills—Epirubicin—sarcoma	0.000673	0.0032	CcSEcCtD
Halofantrine—Pruritus—Etoposide—sarcoma	0.000672	0.0032	CcSEcCtD
Halofantrine—Arrhythmia—Epirubicin—sarcoma	0.00067	0.00319	CcSEcCtD
Halofantrine—Visual impairment—Doxorubicin—sarcoma	0.000668	0.00318	CcSEcCtD
Halofantrine—Diarrhoea—Etoposide—sarcoma	0.00065	0.00309	CcSEcCtD
Halofantrine—Tinnitus—Doxorubicin—sarcoma	0.000647	0.00308	CcSEcCtD
Halofantrine—Back pain—Epirubicin—sarcoma	0.000631	0.00301	CcSEcCtD
Halofantrine—Dizziness—Etoposide—sarcoma	0.000628	0.00299	CcSEcCtD
Halofantrine—Chills—Doxorubicin—sarcoma	0.000622	0.00296	CcSEcCtD
Halofantrine—Arrhythmia—Doxorubicin—sarcoma	0.00062	0.00295	CcSEcCtD
Halofantrine—Ill-defined disorder—Epirubicin—sarcoma	0.000605	0.00288	CcSEcCtD
Halofantrine—Vomiting—Etoposide—sarcoma	0.000604	0.00288	CcSEcCtD
Halofantrine—Rash—Etoposide—sarcoma	0.000599	0.00285	CcSEcCtD
Halofantrine—Dermatitis—Etoposide—sarcoma	0.000598	0.00285	CcSEcCtD
Halofantrine—Headache—Etoposide—sarcoma	0.000595	0.00283	CcSEcCtD
Halofantrine—Malaise—Epirubicin—sarcoma	0.000588	0.0028	CcSEcCtD
Halofantrine—Back pain—Doxorubicin—sarcoma	0.000584	0.00278	CcSEcCtD
Halofantrine—Palpitations—Epirubicin—sarcoma	0.000577	0.00275	CcSEcCtD
Halofantrine—Cough—Epirubicin—sarcoma	0.000569	0.00271	CcSEcCtD
Halofantrine—Convulsion—Epirubicin—sarcoma	0.000565	0.00269	CcSEcCtD
Halofantrine—Nausea—Etoposide—sarcoma	0.000564	0.00269	CcSEcCtD
Halofantrine—Ill-defined disorder—Doxorubicin—sarcoma	0.00056	0.00267	CcSEcCtD
Halofantrine—Chest pain—Epirubicin—sarcoma	0.000555	0.00264	CcSEcCtD
Halofantrine—Myalgia—Epirubicin—sarcoma	0.000555	0.00264	CcSEcCtD
Halofantrine—Arthralgia—Epirubicin—sarcoma	0.000555	0.00264	CcSEcCtD
Halofantrine—Discomfort—Epirubicin—sarcoma	0.000549	0.00261	CcSEcCtD
Halofantrine—Malaise—Doxorubicin—sarcoma	0.000544	0.00259	CcSEcCtD
Halofantrine—Confusional state—Epirubicin—sarcoma	0.000537	0.00256	CcSEcCtD
Halofantrine—Palpitations—Doxorubicin—sarcoma	0.000534	0.00254	CcSEcCtD
Halofantrine—Anaphylactic shock—Epirubicin—sarcoma	0.000532	0.00254	CcSEcCtD
Halofantrine—Cough—Doxorubicin—sarcoma	0.000527	0.00251	CcSEcCtD
Halofantrine—Convulsion—Doxorubicin—sarcoma	0.000523	0.00249	CcSEcCtD
Halofantrine—Myalgia—Doxorubicin—sarcoma	0.000514	0.00245	CcSEcCtD
Halofantrine—Arthralgia—Doxorubicin—sarcoma	0.000514	0.00245	CcSEcCtD
Halofantrine—Chest pain—Doxorubicin—sarcoma	0.000514	0.00245	CcSEcCtD
Halofantrine—Discomfort—Doxorubicin—sarcoma	0.000508	0.00242	CcSEcCtD
Halofantrine—Anorexia—Epirubicin—sarcoma	0.000508	0.00242	CcSEcCtD
Halofantrine—Confusional state—Doxorubicin—sarcoma	0.000497	0.00237	CcSEcCtD
Halofantrine—Anaphylactic shock—Doxorubicin—sarcoma	0.000493	0.00235	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000485	0.00231	CcSEcCtD
Halofantrine—Paraesthesia—Epirubicin—sarcoma	0.000478	0.00228	CcSEcCtD
Halofantrine—Anorexia—Doxorubicin—sarcoma	0.00047	0.00224	CcSEcCtD
Halofantrine—Dyspepsia—Epirubicin—sarcoma	0.000469	0.00223	CcSEcCtD
Halofantrine—Decreased appetite—Epirubicin—sarcoma	0.000463	0.0022	CcSEcCtD
Halofantrine—Fatigue—Epirubicin—sarcoma	0.000459	0.00219	CcSEcCtD
Halofantrine—Constipation—Epirubicin—sarcoma	0.000455	0.00217	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000449	0.00214	CcSEcCtD
Halofantrine—Paraesthesia—Doxorubicin—sarcoma	0.000442	0.00211	CcSEcCtD
Halofantrine—Feeling abnormal—Epirubicin—sarcoma	0.000439	0.00209	CcSEcCtD
Halofantrine—Gastrointestinal pain—Epirubicin—sarcoma	0.000435	0.00207	CcSEcCtD
Halofantrine—Dyspepsia—Doxorubicin—sarcoma	0.000434	0.00207	CcSEcCtD
Halofantrine—Decreased appetite—Doxorubicin—sarcoma	0.000428	0.00204	CcSEcCtD
Halofantrine—Fatigue—Doxorubicin—sarcoma	0.000425	0.00202	CcSEcCtD
Halofantrine—Urticaria—Epirubicin—sarcoma	0.000423	0.00201	CcSEcCtD
Halofantrine—Constipation—Doxorubicin—sarcoma	0.000421	0.00201	CcSEcCtD
Halofantrine—Abdominal pain—Epirubicin—sarcoma	0.000421	0.002	CcSEcCtD
Halofantrine—Feeling abnormal—Doxorubicin—sarcoma	0.000406	0.00193	CcSEcCtD
Halofantrine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000403	0.00192	CcSEcCtD
Halofantrine—Urticaria—Doxorubicin—sarcoma	0.000391	0.00186	CcSEcCtD
Halofantrine—Abdominal pain—Doxorubicin—sarcoma	0.000389	0.00185	CcSEcCtD
Halofantrine—Asthenia—Epirubicin—sarcoma	0.000382	0.00182	CcSEcCtD
Halofantrine—Pruritus—Epirubicin—sarcoma	0.000377	0.00179	CcSEcCtD
Halofantrine—Diarrhoea—Epirubicin—sarcoma	0.000364	0.00173	CcSEcCtD
Halofantrine—Asthenia—Doxorubicin—sarcoma	0.000354	0.00168	CcSEcCtD
Halofantrine—Dizziness—Epirubicin—sarcoma	0.000352	0.00168	CcSEcCtD
Halofantrine—Pruritus—Doxorubicin—sarcoma	0.000349	0.00166	CcSEcCtD
Halofantrine—Vomiting—Epirubicin—sarcoma	0.000339	0.00161	CcSEcCtD
Halofantrine—Diarrhoea—Doxorubicin—sarcoma	0.000337	0.00161	CcSEcCtD
Halofantrine—Rash—Epirubicin—sarcoma	0.000336	0.0016	CcSEcCtD
Halofantrine—Dermatitis—Epirubicin—sarcoma	0.000335	0.0016	CcSEcCtD
Halofantrine—Headache—Epirubicin—sarcoma	0.000334	0.00159	CcSEcCtD
Halofantrine—Dizziness—Doxorubicin—sarcoma	0.000326	0.00155	CcSEcCtD
Halofantrine—Nausea—Epirubicin—sarcoma	0.000316	0.00151	CcSEcCtD
Halofantrine—Vomiting—Doxorubicin—sarcoma	0.000313	0.00149	CcSEcCtD
Halofantrine—Rash—Doxorubicin—sarcoma	0.000311	0.00148	CcSEcCtD
Halofantrine—Dermatitis—Doxorubicin—sarcoma	0.00031	0.00148	CcSEcCtD
Halofantrine—Headache—Doxorubicin—sarcoma	0.000309	0.00147	CcSEcCtD
Halofantrine—Nausea—Doxorubicin—sarcoma	0.000293	0.00139	CcSEcCtD
